Now FDA approved for adults living with schizophrenia

Closeup of a person with a determined gaze.

Focus on your
comeback

WELTRUZA[] is a once-monthly treatment option that
improved symptoms of schizophrenia in an 8-week study*

*In an 8-week clinical study of adults with schizophrenia during an acute exacerbation, WELTRUZA improved Positive and Negative Syndrome Scale (a doctor-rated questionnaire used in studies to measure schizophrenia symptoms) total score at week 8 vs placebo.

People featured are not actual patients, caregivers, or doctors.

A new long-acting injectable treatment is here

Share a bit about yourself to stay connected with the latest information on WELTRUZA and schizophrenia care.

Required field.

I am a:

Please select one of the options.

Please confirm your age.

Please read and agree to all terms and conditions.

Please complete the captcha requirement.